Pharmacyclics, an AbbVie Company

Pharmacyclics, an AbbVie Company

Pharmaceutical Manufacturing

Sunnyvale, CA 28,552 followers

Striving to bring back the magical of normal.

About us

Pharmacyclics is committed to the development and commercialization of novel therapies intended to improve the quality and duration of life and to resolve serious unmet medical needs for cancer patients. Pharmacyclics is a wholly-owned subsidiary of AbbVie (NYSE:ABBV), a global, research-based biopharmaceutical company. Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products and a pipeline containing multiple promising new molecules that are being studied in more than 200 clinical trials for over 20 different types of cancer. More than 1,200 Pharmacyclics and AbbVie research scientists, clinicians, marketing, operations and corporate professionals work in the San Francisco Bay Area. They combine their expertise in immuno-oncology, stem cells, and cell-signaling with their knowledge of bispecific antibodies, antibody-drug conjugates (ADCs), and covalent-inhibitor technologies to discover and develop novel cancer treatments. Together, we are striving to outsmart cancer. Review our LinkedIn community guidelines at http://bit.ly/AbbVieSocialGuidelines.

Website
http://www.pharmacyclics.com
Industry
Pharmaceutical Manufacturing
Company size
1,001-5,000 employees
Headquarters
Sunnyvale, CA
Type
Public Company
Founded
1991

Locations

Employees at Pharmacyclics, an AbbVie Company

Updates

Affiliated pages

Similar pages

Browse jobs

Funding